Xuefeng Li

Dr. Xuefeng Li


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
YMyoujun mi
youjun mi
TXtao xie
tao xie
BZBingdong Zhu
Bingdong Zhu
JTJiying Tan
Jiying Tan
XLXuefeng Li
Xuefeng Li
JWJuan Wang
Juan Wang
Coronavirus disease (COVID-19) causes a serious threat to human health. Virus-like particles (VLPs) constitute a promising platform in SARS-CoV-2 vaccine development. In this study, the E, M, and S genes were cloned into multiple cloning sites of a new triple expression plasmid with one p10 promoter, two pPH promoters, and three multiple cloning sites. The plasmid was transformed into DH10 BacTMEscherichia coli competent cells to obtain recombinant bacmid. Then the recombinant bacmid was transfected in ExpiSf9TM insect cells to generate recombinant baculovirus. After ExpiSf9TM cells infection with the recombinant baculovirus, the E, M, and S proteins were expressed in insect cells. Finally, SARS-CoV-2 VLPs were self-assembled in insect cells after infection. The morphology and the size of SARS-CoV-2 VLPs are similar to the native virions.

9 March 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YWYudong Wang
Yudong Wang
JZJianing Zhang
Jianing Zhang
ZXZheng Xu
Zheng Xu
GZGuifang Zhang
Guifang Zhang
HLHuijuan Lv
Huijuan Lv
YSYanbin Shi
Yanbin Shi

30 October 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HLHuijuan Lv
Huijuan Lv
JNJingjing Niu
Jingjing Niu
WPWenhao Pan
Wenhao Pan
YWYudong Wang
Yudong Wang
LWLifang Wang
Lifang Wang
YSYanbin Shi
Yanbin Shi

1 June 2020 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
XLXuefeng Li
Xuefeng Li
JZJing Zhou
Jing Zhou
YDYinghuan Dou
Yinghuan Dou
YSYanbin Shi
Yanbin Shi
YWYing Wang
Ying Wang
XWXiangxiang Wei
Xiangxiang Wei
Background: Angelica root is the dry root of the Umbelliferae plantAngelica sinensis (oliv) Diels. Angelica organic acid (OA) is the main active ingredient in Angelica sinensis, and it exerts potential anti-atherosclerotic effects by preventing Oxidized low-density lipoprotein (Ox-LDL) induced endothelial injury. To study the protective effects of OA on ox-LDL-induced HUVECs autophagic flux dysfunction and inflammatory injury.Methods: OA were isolated by water extraction and alcohol precipitation, and then the content of ferulic acid (FA) in the OA was determined by high performance liquid chromatography. The ox-LDL-induced endothelial injury model was established. The effect of ferulic acid on the survival of Human umbilical vein endothelial cells (HVUECs) was detected by CCK-8 assay. HUVECs were pretreated with different concentrations of OA (20 μmol/L, 40 μmol/L, and 80 μmol/L), and Western Blot was used to detect the expressions of LC3II, p62, MCP-1, VCAM-1 and LOX-1. The autophagosomes in HUVECs were observed by transmission electron microscopy (TEM).Results: 20 μmol/L OA could increase the expression of LC3II and decrease the expression of p62, MCP-1, VCAM-1 and LOX-1. The results of TEM showed that angelica organic acids promoted cell organelle degradation in autolysosomes.Conclusion: OA could reduce inflammation, protect endothelial cells and play an anti-atherosclerotic role by enhancing the autophagy flux of damaged endothelial cells, in which FA the major active ingredient of OA played a major role.

10 June 2023 in Chinese Herbal Medicines
Verified
Journal Article
Open access
HWHuaijian Wang
Huaijian Wang
YTYing Tian
Ying Tian
HTHao Tan
Hao Tan
MZMengru Zhou
Mengru Zhou
MLMiao Li
Miao Li
XLXuefeng Li
Xuefeng Li
Some Chinese herbs have been used to prevent and treat diseases, and are also used as common food ingredients. These Chinese herbs are potential resource for research and development of new drugs. Leek roots is a typical medicine of food and medicine continuum. It has a long history of medicinal applications and edible food in China. In this paper, the origin, biological active components, pharmacological action and clinical application of leek roots were introduced. We hope that this review will contribute to the development of leek roots for pharmaceutical research and clinical applications, as well as related health products.

1 October 2022
Verified
Journal Article
Closed access
JZJiaying Zhang
Jiaying Zhang
XWXiangxiang Wei
Xiangxiang Wei
XLXuefeng Li
Xuefeng Li
YYYang Yuan
Yang Yuan
YDYinghuan Dou
Yinghuan Dou
FTFeifei Tian
Feifei Tian